Developer docs
API playgroundTry for free, no card

Search company profiles

Premier Medical Laboratory Services

Full company profile

uuid000tq75

Namestring
Premier Medical Laboratory Services
Legal namestring
Premier Medical Laboratory Services
Websiteurl
premedinc.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Premier Medical Laboratory Services (PMLS / Premier Medical Labs) is a privately held reference laboratory based in Greenville, South Carolina, founded in 2015 and operating with 51-100 employees. The company provides diagnostic testing services to healthcare providers and physicians, offering a multi-modality menu that includes Liquid Chromatography-Mass Spectrometry (LCMS), Molecular diagnostics (notably COVID-19 testing), and Allergy testing from its facility at 6000A Pelham Road. Its stated value proposition centers on equipping physicians with laboratory data to inform patient care, supported by modern instrumentation across these three modalities.

The company monetizes through transaction-fee laboratory testing billed to healthcare benefit programs, including federal government payors. During the COVID-19 pandemic period, PMLS scaled test processing capacity and operated as a subcontractor to e3Health Solutions LLC, processing and reporting hundreds of thousands of COVID-19 tests. As of March 2026, the company's owner Kevin S. Murdock (along with Thomas C. Lee and Vidhya V. Narayanan) was indicted by a federal grand jury on 16 counts of healthcare fraud and conspiracy related to COVID-19 test billing practices involving pooled-versus-individual test reimbursement schemes. Murdock had previously agreed to a $27.5 million civil consent judgment in a related case brought by the United States and the States of Colorado, Georgia, and South Carolina.

Operationally the lab remains active per its website and contact channels, serving physicians and clinics primarily in the Southeast United States. The company has no disclosed institutional investors, parent entities, or subsidiaries, and ownership remains concentrated with the indicted founder. No patents, trademarks, regulatory certifications, or formal awards are documented in available sources. The combination of leadership-level criminal exposure, a multi-million-dollar civil consent judgment, and the absence of disclosed diversification beyond regional physician-clinic testing defines the company's current risk profile.

Short descriptiontext

Premier Medical Laboratory Services is a Greenville, South Carolina-based reference laboratory providing LCMS, Molecular, and Allergy diagnostic testing to physicians and clinics in the Southeast United States.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersGreenville, United States
HQ citystring
Greenville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical laboratory services, molecular diagnostics, allergy testing, COVID-19 testing, reference laboratory
Industry3 codes
1Reference & Esoteric Testing Laboratories
CodeHLAFAMAJPrimaryYes
2Central Laboratory Services (Core Lab Operations)
CodeHLAGAEAAPrimaryNo
3Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays)
CodeHLAAAMACPrimaryNo
NAICS code1 code
  • Medical Laboratories621511
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Diagnostic Laboratory Services
Social media profiles2 records
Revenue model1 record
1Laboratory Testing Services
TypeTransaction Fee
Description

Revenue generated from processing COVID-19 tests billed to healthcare benefit programs including federal government programs. The scheme involved billing for individual tests when tests were actually pooled together.

foxcarolina.com
Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Premier Medical Laboratory Services operates as a reference laboratory providing diagnostic testing services to healthcare providers and physicians. Its core testing capabilities include LCMS (Liquid Chromatography-Mass Spectrometry), Molecular diagnostics (including COVID-19 testing), and Allergy testing. The lab processes and reports test results to support physicians in delivering patient care.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Premier Medical Laboratory Services operates as a reference laboratory providing diagnostic testing services. The company offers a portfolio of testing capabilities including LCMS (Liquid Chromatography-Mass Spectrometry), Molecular testing (including COVID-19 testing), and Allergy testing. These services are designed to support physicians in providing optimal patient care, with a commitment to listening to and serving their clients. The laboratory has processed hundreds of thousands of COVID-19 tests and operates with modern equipment for LCMS, Molecular, and Allergy testing.

Product and service1 record
1Reference Laboratory Services
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Premier Medical Laboratory Services operated as a subcontractor for e3Health Solutions LLC, processing and reporting hundreds of thousands of COVID-19 tests through this partnership arrangement.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

One of the two largest U.S. clinical reference laboratories, offering a broad menu of routine and esoteric diagnostics. Directly comparable as a reference lab serving physicians with similar test categories (molecular, allergy, LCMS-based assays), but at vastly larger scale.

TypeDirect peer
Description

Independent U.S. reference laboratory specializing in toxicology and esoteric testing using LCMS and other advanced analytical platforms. Highly comparable to PMLS on the LCMS-based testing portion of the menu.

TypeDirect peer
Description

Full-service U.S. reference laboratory offering molecular, allergy, and specialty esoteric testing to physicians, hospitals, and clinics. Closely comparable in menu breadth and customer type to PMLS.

TypeDirect peer
Description

Reference laboratory arm of Mayo Clinic offering esoteric and specialty testing (molecular, allergy, mass spectrometry). Comparable to PMLS in serving as a higher-complexity reference lab for physician clients across the U.S.

TypeDirect peer
Description

A large nonprofit reference laboratory affiliated with the University of Utah, specializing in esoteric and complex testing including LCMS, molecular diagnostics, and allergy. Closely comparable in menu depth and physician-client orientation.

TypeBroad incumbent
Description

The other major U.S. reference laboratory with a comprehensive menu including molecular, allergy, and LCMS-based specialty testing. Comparable business model and customer base (physicians and hospitals) to PMLS, but operating nationally.

TypeBroad incumbent
Description

Subsidiary of global diagnostics group Sonic Healthcare, operating a network of U.S. reference labs including esoteric testing. Comparable as a multi-modality reference laboratory serving physician clients.

TypeEmerging player
Description

Specialty reference laboratory focused on molecular and genetic diagnostics, serving physicians and hospitals. Partial overlap with PMLS's molecular diagnostics offering.

TypeOthers
Description

Major diagnostics equipment and testing services provider (including its specialty esoteric testing labs via the PPD/acquired units). Comparable on the LCMS instrumentation side and the broader clinical diagnostics services market PMLS operates in.

TypeDirect peer
Description

Specialty reference lab focused on infectious disease, immunology, and molecular diagnostics for clinical and trial clients. Directly comparable to PMLS in molecular and specialty testing services for healthcare providers.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Premier Medical Laboratory Services

Diagnostic Laboratory Servicespremedinc.com

Premier Medical Laboratory Services is a Greenville, South Carolina-based reference laboratory providing LCMS, Molecular, and Allergy diagnostic testing to physicians and clinics in the Southeast United States.

What Premier Medical Laboratory Services does

Premier Medical Laboratory Services (PMLS / Premier Medical Labs) is a privately held reference laboratory based in Greenville, South Carolina, founded in 2015 and operating with 51-100 employees. The company provides diagnostic testing services to healthcare providers and physicians, offering a multi-modality menu that includes Liquid Chromatography-Mass Spectrometry (LCMS), Molecular diagnostics (notably COVID-19 testing), and Allergy testing from its facility at 6000A Pelham Road. Its stated value proposition centers on equipping physicians with laboratory data to inform patient care, supported by modern instrumentation across these three modalities.

The company monetizes through transaction-fee laboratory testing billed to healthcare benefit programs, including federal government payors. During the COVID-19 pandemic period, PMLS scaled test processing capacity and operated as a subcontractor to e3Health Solutions LLC, processing and reporting hundreds of thousands of COVID-19 tests. As of March 2026, the company's owner Kevin S. Murdock (along with Thomas C. Lee and Vidhya V. Narayanan) was indicted by a federal grand jury on 16 counts of healthcare fraud and conspiracy related to COVID-19 test billing practices involving pooled-versus-individual test reimbursement schemes. Murdock had previously agreed to a $27.5 million civil consent judgment in a related case brought by the United States and the States of Colorado, Georgia, and South Carolina.

Operationally the lab remains active per its website and contact channels, serving physicians and clinics primarily in the Southeast United States. The company has no disclosed institutional investors, parent entities, or subsidiaries, and ownership remains concentrated with the indicted founder. No patents, trademarks, regulatory certifications, or formal awards are documented in available sources. The combination of leadership-level criminal exposure, a multi-million-dollar civil consent judgment, and the absence of disclosed diversification beyond regional physician-clinic testing defines the company's current risk profile.

Premier Medical Laboratory Services firmographics

Firmographics
Name
Premier Medical Laboratory Services
Legal name
Premier Medical Laboratory Services
Website
https://premedinc.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
Premier Medical Laboratory Services is a Greenville, South Carolina-based reference laboratory providing LCMS, Molecular, and Allergy diagnostic testing to physicians and clinics in the Southeast United States.
Ownership category
akta.pro rank

Premier Medical Laboratory Services industry classification

Industry
Product category
Diagnostic Laboratory Services
NAICS
Medical Laboratories (621511)
SIC
Services-Medical Laboratories (8071)
akta.pro primary industry
Reference & Esoteric Testing Laboratories (HLAFAMAJ)
akta.pro secondary industries
Central Laboratory Services (Core Lab Operations) (HLAGAEAA), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC)

Keywords

  • Clinical laboratory services
  • Molecular diagnostics
  • Allergy testing
  • COVID-19 testing
  • Reference laboratory

Where Premier Medical Laboratory Services is headquartered

Location

Headquarters

HQ city
Greenville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Premier Medical Laboratory Services business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Laboratory Testing Services: Revenue generated from processing COVID-19 tests billed to healthcare benefit programs including federal government programs. The scheme involved billing for individual tests when tests were actually pooled together.

Premier Medical Laboratory Services product offering

Product offering

Core offering

Premier Medical Laboratory Services operates as a reference laboratory providing diagnostic testing services to healthcare providers and physicians. Its core testing capabilities include LCMS (Liquid Chromatography-Mass Spectrometry), Molecular diagnostics (including COVID-19 testing), and Allergy testing. The lab processes and reports test results to support physicians in delivering patient care.

Product overview

Premier Medical Laboratory Services operates as a reference laboratory providing diagnostic testing services. The company offers a portfolio of testing capabilities including LCMS (Liquid Chromatography-Mass Spectrometry), Molecular testing (including COVID-19 testing), and Allergy testing. These services are designed to support physicians in providing optimal patient care, with a commitment to listening to and serving their clients. The laboratory has processed hundreds of thousands of COVID-19 tests and operates with modern equipment for LCMS, Molecular, and Allergy testing.

Differentiator

Problem solved

Functional benefit

Products and services

  • Reference Laboratory Services

Companies that use Premier Medical Laboratory Services

Customer profile

Segments1 record

Ideal customer profiles1 record

Premier Medical Laboratory Services technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Premier Medical Laboratory Services partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • e3Health Solutions LLCcoreStrategic or Co-development PartnerPremier Medical Laboratory Services operated as a subcontractor for e3Health Solutions LLC, processing and reporting hundreds of thousands of COVID-19 tests through this partnership arrangement.

Scale indicators2 records

Recent moves5 records

Expansion highlights3 records

Premier Medical Laboratory Services competitors and assessment

Company assessment

Broad incumbents

  • Quest Diagnostics: One of the two largest U.S. clinical reference laboratories, offering a broad menu of routine and esoteric diagnostics. Directly comparable as a reference lab serving physicians with similar test categories (molecular, allergy, LCMS-based assays), but at vastly larger scale.
  • Laboratory Corporation of America (Labcorp): The other major U.S. reference laboratory with a comprehensive menu including molecular, allergy, and LCMS-based specialty testing. Comparable business model and customer base (physicians and hospitals) to PMLS, but operating nationally.
  • Sonic Healthcare USA: Subsidiary of global diagnostics group Sonic Healthcare, operating a network of U.S. reference labs including esoteric testing. Comparable as a multi-modality reference laboratory serving physician clients.

Direct peers

  • NMS Labs: Independent U.S. reference laboratory specializing in toxicology and esoteric testing using LCMS and other advanced analytical platforms. Highly comparable to PMLS on the LCMS-based testing portion of the menu.
  • BioReference Laboratories (an OPKO Health Company): Full-service U.S. reference laboratory offering molecular, allergy, and specialty esoteric testing to physicians, hospitals, and clinics. Closely comparable in menu breadth and customer type to PMLS.
  • Mayo Clinic Laboratories: Reference laboratory arm of Mayo Clinic offering esoteric and specialty testing (molecular, allergy, mass spectrometry). Comparable to PMLS in serving as a higher-complexity reference lab for physician clients across the U.S.
  • ARUP Laboratories: A large nonprofit reference laboratory affiliated with the University of Utah, specializing in esoteric and complex testing including LCMS, molecular diagnostics, and allergy. Closely comparable in menu depth and physician-client orientation.
  • Eurofins Viracor BioPharma Services: Specialty reference lab focused on infectious disease, immunology, and molecular diagnostics for clinical and trial clients. Directly comparable to PMLS in molecular and specialty testing services for healthcare providers.

Emerging players

Others

  • Thermo Fisher Scientific (Clinical Diagnostics): Major diagnostics equipment and testing services provider (including its specialty esoteric testing labs via the PPD/acquired units). Comparable on the LCMS instrumentation side and the broader clinical diagnostics services market PMLS operates in.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights4 records

Customer concentration

Premier Medical Laboratory Services social profiles

Digital presence

Premier Medical Laboratory Services financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Premier Medical Laboratory Services leadership team

Management profile

Number of profiles

Profiles1 record

Premier Medical Laboratory Services funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Premier Medical Laboratory Services M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Premier Medical Laboratory Services

What does Premier Medical Laboratory Services do?

Premier Medical Laboratory Services operates as a reference laboratory providing diagnostic testing services to healthcare providers and physicians. Its core testing capabilities include LCMS (Liquid Chromatography-Mass Spectrometry), Molecular diagnostics (including COVID-19 testing), and Allergy testing. The lab processes and reports test results to support physicians in delivering patient care.

Is Premier Medical Laboratory Services a public or private company?

Premier Medical Laboratory Services is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Premier Medical Laboratory Services founded?

Premier Medical Laboratory Services was founded in 2015. It employs 51 to 100 people.

Where is Premier Medical Laboratory Services based?

Premier Medical Laboratory Services is headquartered in Greenville, United States, in the North America region.

How does Premier Medical Laboratory Services make money?

One revenue line is on record: laboratory Testing Services.

Who are Premier Medical Laboratory Services's main competitors?

Broad incumbents on record are Quest Diagnostics, Laboratory Corporation of America (Labcorp) and Sonic Healthcare USA. Direct peers are NMS Labs, BioReference Laboratories (an OPKO Health Company), Mayo Clinic Laboratories, ARUP Laboratories and Eurofins Viracor BioPharma Services. Baylor Genetics (a Division of Miraca Holdings) is listed as an emerging player. Thermo Fisher Scientific (Clinical Diagnostics) is listed as an others.

Does Premier Medical Laboratory Services have an API?

No public API is recorded for Premier Medical Laboratory Services.

What industry is Premier Medical Laboratory Services in?

Premier Medical Laboratory Services's product category is Diagnostic Laboratory Services. Its primary akta.pro industry code is HLAFAMAJ, Reference & Esoteric Testing Laboratories, with a secondary code of HLAGAEAA, Central Laboratory Services (Core Lab Operations). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
https://www.foxcarolina.comFormer Greenville lab CEO indicted in multi-million dollar COVID testing fraud schemeA federal grand jury in Greenville, South Carolina returned a 16-count indictment charging Kevin S. Murdock, Thomas C. Lee, and Vidhya V. Narayanan with health care fraud and conspiracy to commit health care fraud tied to COVID-19 testing. The three devised a scheme to fraudulently generate revenue from health care benefit programs while working as a subcontractor for e3Health Solutions LLC, processing and reporting hundreds of thousands of COVID-19 tests through Murdock's Premier Medical Laboratory Services. The scheme generated millions in unwarranted payments, with each defendant facing up to 10 years in prison and a $250,000 fine, and Murdock previously agreed to a $27.5 million consent judgment in a related civil case.WYFFGreenville lab owner indicted in COVID-19 testing fraudA federal grand jury indicted Kevin S. Murdock, owner of Premier Medical Laboratory Services in Greenville, South Carolina, along with two employees, for a multi-part scheme to defraud healthcare benefit programs through false COVID-19 testing claims. The defendants allegedly billed the federal government for individual tests when tests were actually pooled together and manipulated processing software, generating millions in fraudulent proceeds. Murdock previously agreed to a consent judgment of $27,544,460 in a civil action brought by the United States and the States of Colorado, Georgia, and South Carolina.PR NewswirePremier Medical Laboratory Services Hires Bioinformatics Expert, Dr. Daniel HughesPremier Medical Laboratory Services (PMLS) has appointed Dr. Daniel Hughes as its new Director of Bioinformatics, leveraging his extensive background in genomics and cancer research to lead scientific development initiatives. This strategic hire aims to enhance PMLS's capabilities in areas such as risk scores and COVID-19 variant identification through advanced laboratory technologies.Patch4 ‘Stealth Omicron’ Cases Found In FL, 2 In Miami-Dade: ReportFour cases of the 'stealth omicron' variant (BA.2) were detected in Florida, with two confirmed in Miami-Dade County by Premier Medical Laboratory Services and two others identified earlier in the week. These findings occur amidst a general decline in new coronavirus cases in the state, which reported 133,000 new infections from Jan. 28 to Feb. 3. While the variant has been reported in 40 countries globally, experts warn it is highly contagious despite uncertainty regarding its severity compared to the parent BA.1 variant.PR NewswireNew Stealth Omicron BA.2 Variant Identified by Premier Medical Laboratory ServicesPremier Medical Laboratory Services identified one of the first US cases of the Omicron BA.2 subvariant, dubbed "stealth omicron," in a patient from Florida. The BA.2 variant lacks the S-gene dropout characteristic found in the original Omicron strain, making it difficult to detect via standard PCR testing and leading to increased transmissibility observed in Denmark. This identification adds to the global surveillance data as the variant spreads across 57 countries.PR NewswireOmicron Variant Spreads Throughout South CarolinaPremier Medical Laboratory Services (PMLS), headquartered in Greenville, South Carolina, has confirmed the presence of the Omicron variant in the state's Upstate region through Next Generation Sequencing surveillance. The detection was conducted in partnership with Clemson University's Bioengineering Department and REDDI Lab, with COVID-19 positive samples collected under National Institutes of Health funding. PMLS highlights its capacity to sequence up to 42,000 samples per week as part of one of the nation's largest sequencing initiatives for tracking virus mutations and spread.PR NewswirePremier Medical Laboratory Services Welcomes New Chief Commercial Officer, Jeff SchmalzPremier Medical Laboratory Services appointed Jeff Schmalz as its new Chief Commercial Officer to lead lab growth initiatives including partnerships and product development. Schmalz brings 35 years of experience in the diagnostics market, having previously driven significant revenue growth at companies such as LabCorp and Abbott. This leadership change aims to support PMLS's mission to advance advanced medical diagnostics for patient outcomes.PR NewswireSouth Carolina Scientists Tackle COVID MisconceptionsPremier Medical Laboratory Services (PMLS) announced it will host a digital event on September 23, 2021, where its scientists will discuss COVID-19 topics including the delta variant and vaccines to combat misinformation. Dr. Brian Krueger and Dr. Stewart Holt, scientists at the largest lab in the southeast, will lead the panel discussion aimed at informing South Carolinians. According to DHEC, approximately 50% of South Carolinians are fully vaccinated, with the new Biden Administration vaccine mandate contributing to increased hesitancy among some populations.PR NewswireU.S. Senator Lindsey Graham Speaks on The Importance of Variant Tracking Amid Increasing Spread of the Delta VariantUS Senator Lindsey Graham visited Premier Medical Laboratory Services in Greenville, South Carolina, on June 17, 2021, to observe one of the nation's largest COVID-19 variant surveillance initiatives using Next Generation Sequencing technology. The laboratory has the capacity to monitor 84,000 COVID samples per week, enabling detection of the Delta variant and other emerging mutations for the CDC and state health departments. PMLS plans to continue providing variant data to support the US COVID-19 response as the Delta variant, which is approximately 40% more contagious than the original strain, spreads through the country.PR NewswireRutgers University and Premier Medical Laboratory Services Conduct Studies Showing TAG-NGPM+™ Inactivates SARS CoV-2 Virus, Increases StabilityRutgers New Jersey Medical School's Public Health Research Institute and Premier Medical Laboratory Services conducted collaborative studies testing Truckee Applied Genomics' TAG-NGPM+ virus inactivating transport media, finding it inactivates SARS-CoV-2 within 30 minutes while preserving viral RNA integrity and maintaining stability at room temperature. The solution enables safer handling of COVID-19 test specimens by eliminating the need for cold chain storage and reducing biohazard risks for laboratory personnel, potentially simplifying point-of-care testing at locations like doctor's offices, workplaces, and schools. The research findings are scheduled to be published in a peer-reviewed journal.